CDK4 and neoplasm: Pairing DNMT inhibition with CDK4/6 inhibitors may couple tumor-intrinsic restoration of antigen presentation to favorable immune remodeling, as CDK4/6 blockade increases tumor cell antigen-presentation gene expression and reduces regulatory T-cell proliferation, enhancing cytotoxic responses.